RT - Article
SR - Electronic
T1 - 
SP - 2020-12-03
DO - 10.1016/S0735-1097(20)30759-2
A1 - , 
A1 - , 
A1 - , 
A1 - , 
A1 - , 
A1 - , 
A1 - , 
YR - 2020
UL - https://repo.bashgmu.ru/publication/885
AB - The biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3) have emerged as potential powerful tools in stratifying the risk of unfavorable cardiovascular events in cardiac patients in post-MI period. Goal was to investigate the potential prognostic power of the biomarkers ST2, Ptx-3 andNT-proBNP in cardiovascular events risk stratification in 2 years FU after STEMI.